Comparison of Cephalexin Versus Clindamycin for Suspected CA-MRSA Skin Infections

PHASE4CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

May 31, 2009

Study Completion Date

August 31, 2009

Conditions
Staphylococcal InfectionAbscessStaphylococcal Skin InfectionFolliculitis
Interventions
DRUG

clindamycin

clindamycin suspension or tablets, 20mg/kg/day, given by mouth, divided TID, for 7 days

DRUG

cephalexin

cephalexin suspension or tablets, 40mg/kg/day, given by mouth, divided TID, for 7 days

Trial Locations (1)

21287

Johns Hopkins University, Baltimore

All Listed Sponsors
collaborator

Thrasher Research Fund

OTHER

collaborator

Johns Hopkins University

OTHER

lead

Aaron Chen

OTHER

NCT00352612 - Comparison of Cephalexin Versus Clindamycin for Suspected CA-MRSA Skin Infections | Biotech Hunter | Biotech Hunter